These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16129338)

  • 1. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
    Nair V
    Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marek's disease: an update on oncogenic mechanisms and control.
    Venugopal K
    Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
    Davison F; Nair V
    Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease: the continuing struggle between pathogen and host.
    Witter RL
    Vet J; 2005 Sep; 170(2):149-50. PubMed ID: 16129335
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marek's disease vaccines: a solution for today but a worry for tomorrow?
    Gimeno IM
    Vaccine; 2008 Jul; 26 Suppl 3():C31-41. PubMed ID: 18773529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful control of Marek's disease by vaccination.
    Nair V
    Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
    Reddy SM; Izumiya Y; Lupiani B
    Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marek's disease and new approaches to its control.
    Zelník V
    Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased virulence of Marek's disease virus field isolates.
    Witter RL
    Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development.
    Sharma JM
    Avian Dis; 1987; 31(3):570-6. PubMed ID: 2823773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of host genetics on Marek's disease virus evolution.
    Hunt HD; Dunn JR
    Avian Dis; 2013 Jun; 57(2 Suppl):474-82. PubMed ID: 23901764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA
    Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.